title: The role of PET/CT in the management of cervical cancer.
abstract: OBJECTIVE. Cervical cancer is the second most common malignancy in women worldwide and the third most common cause of cancer mortality in the United States. The aim of this article is to describe cervical cancer and outline the value of (18)F-FDG PET/CT in the management of cervical malignancy. CONCLUSION. The value of PET/CT has been found in staging and treatment strategy for cervical cancer. FDG PET/CT facilitates decision-making and radiation treatment planning and provides important information about treatment response, disease recurrence, and long-term survival.
authors.affiliation: Russell H. Morgan Department of Radiology and Radiologic Science, Johns Hopkins University, JHOC 3235, 601 N Caroline St, Baltimore MD 21287, USA.
authors.forename: Sahar
authors.initials: S
authors.lastname: Mirpour
authors.forename: Joyce C
authors.initials: JC
authors.lastname: Mhlanga
authors.forename: Prashanti
authors.initials: P
authors.lastname: Logeswaran
authors.forename: Gregory
authors.initials: G
authors.lastname: Russo
authors.forename: Gustavo
authors.initials: G
authors.lastname: Mercier
authors.forename: Rathan M
authors.initials: RM
authors.lastname: Subramaniam
mesh_terms: D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D064847:Multimodal Imaging; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D002583:Uterine Cervical Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18